Manufactured from the patient’s own blood, CellProtect is said to be the first drug candidate consisting of autologous ex-vivo activated and expanded natural killer (NK) cells. The company has performed a clinical phase I/II trial […]
The drug giant is seeking permission to expand the drug’s uses to include first-line treatment of metastatic non-small-cell lung cancer (NSCLC) in patients whose tumours express EGFR mutations. The submission rides on data from the […]
Ozempic is an analogue of human glucagon-like peptide-1 and was reviewed based on the results of eight Phase IIIa clinical trials in the SUSTAIN programme. The drug is recommended to be taken once-weekly as a […]
The continuing Temperature Assurance Knowledge series of webinars from Sonoco ThermoSafe will continue on Jan. 8, 11 a.m. (EST) to address the questions around single-use vs. reusable packaging for the pharma cold chain. Shipment lanes, […]